251 related articles for article (PubMed ID: 12879488)
1. Study of degradation pathways of Amadori compounds obtained by glycation of opioid pentapeptide and related smaller fragments: stability, reactions, and spectroscopic properties.
Jakas A; Horvat S
Biopolymers; 2003 Aug; 69(4):421-31. PubMed ID: 12879488
[TBL] [Abstract][Full Text] [Related]
2. The effect of glycation on the chemical and enzymatic stability of the endogenous opioid peptide, leucine-enkephalin, and related fragments.
Jakas A; Horvat S
Bioorg Chem; 2004 Dec; 32(6):516-26. PubMed ID: 15530992
[TBL] [Abstract][Full Text] [Related]
3. Transformations of bioactive peptides in the presence of sugars--characterization and stability studies of the adducts generated via the Maillard reaction.
Roscić M; Horvat S
Bioorg Med Chem; 2006 Jul; 14(14):4933-43. PubMed ID: 16563774
[TBL] [Abstract][Full Text] [Related]
4. Formation of reactive intermediates from Amadori compounds under physiological conditions.
Zyzak DV; Richardson JM; Thorpe SR; Baynes JW
Arch Biochem Biophys; 1995 Jan; 316(1):547-54. PubMed ID: 7840665
[TBL] [Abstract][Full Text] [Related]
5. Peptide and amino acid glycation: new insights into the Maillard reaction.
Horvat S; Jakas A
J Pept Sci; 2004 Mar; 10(3):119-37. PubMed ID: 15113085
[TBL] [Abstract][Full Text] [Related]
6. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
[TBL] [Abstract][Full Text] [Related]
7. The Maillard reaction induced modifications of endogenous opioid peptide enkephalin.
Jakas A
Methods Mol Biol; 2013; 1081():137-49. PubMed ID: 24014438
[TBL] [Abstract][Full Text] [Related]
8. Fructose-induced N-terminal glycation of enkephalins and related peptides.
Jakas A; Vinković M; Smrecki V; Sporec M; Horvat S
J Pept Sci; 2008 Aug; 14(8):936-45. PubMed ID: 18351710
[TBL] [Abstract][Full Text] [Related]
9. The early glycation products of the Maillard reaction: mass spectrometric characterization of novel imidazolidinones derived from an opioid pentapeptide and glucose.
Roscić M; Versluis C; Kleinnijenhuis AJ; Horvat S; Heck AJ
Rapid Commun Mass Spectrom; 2001; 15(12):1022-9. PubMed ID: 11400213
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation of lysine-containing pentapeptides by glucuronic acid: new insights into the Maillard reaction.
Horvat S; Roscić M
Carbohydr Res; 2010 Feb; 345(3):377-84. PubMed ID: 20034621
[TBL] [Abstract][Full Text] [Related]
11. Formation pathways and opioid activity data for 3-hydroxypyridinium compounds derived from glucuronic acid and opioid peptides by Maillard processes.
Horvat S; Roscić M; Lemieux C; Nguyen TM; Schiller PW
Chem Biol Drug Des; 2007 Jul; 70(1):30-9. PubMed ID: 17630992
[TBL] [Abstract][Full Text] [Related]
12. Site-specific synthesis of Amadori-modified peptides on solid phase.
Frolov A; Singer D; Hoffmann R
J Pept Sci; 2006 Jun; 12(6):389-95. PubMed ID: 16342332
[TBL] [Abstract][Full Text] [Related]
13. N-Terminal pyrazinones: a new class of peptide-bound advanced glycation end-products.
Krause R; Kühn J; Penndorf I; Knoll K; Henle T
Amino Acids; 2004 Aug; 27(1):9-18. PubMed ID: 15309567
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
Szwergold BS
Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
[TBL] [Abstract][Full Text] [Related]
15. Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose.
Nakamura K; Nakazawa Y; Ienaga K
Biochem Biophys Res Commun; 1997 Mar; 232(1):227-30. PubMed ID: 9125137
[TBL] [Abstract][Full Text] [Related]
16. Glycation of a lysine-containing tetrapeptide by D-glucose and D-fructose--influence of different reaction conditions on the formation of Amadori/Heyns products.
Jakas A; Katić A; Bionda N; Horvat S
Carbohydr Res; 2008 Sep; 343(14):2475-80. PubMed ID: 18656854
[TBL] [Abstract][Full Text] [Related]
17. Maillard reaction products in tissue proteins: new products and new perspectives.
Thorpe SR; Baynes JW
Amino Acids; 2003 Dec; 25(3-4):275-81. PubMed ID: 14661090
[TBL] [Abstract][Full Text] [Related]
18. Non-enzymatic model glycation reactions--a comprehensive study of the reactivity of a modified arginine with aldehydic and diketonic dicarbonyl compounds by electrospray mass spectrometry.
Saraiva MA; Borges CM; Florêncio MH
J Mass Spectrom; 2006 Jun; 41(6):755-70. PubMed ID: 16646000
[TBL] [Abstract][Full Text] [Related]
19. Interplay between the maillard reaction and lipid peroxidation in biochemical systems.
Hidalgo FJ; Zamora R
Ann N Y Acad Sci; 2005 Jun; 1043():319-26. PubMed ID: 16037254
[TBL] [Abstract][Full Text] [Related]
20. In-depth mechanistic study on the formation of acrylamide and other vinylogous compounds by the maillard reaction.
Stadler RH; Robert F; Riediker S; Varga N; Davidek T; Devaud S; Goldmann T; Hau J; Blank I
J Agric Food Chem; 2004 Aug; 52(17):5550-8. PubMed ID: 15315399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
